SCHEMBL6591256

SCHEMBL6591256

Cc1c(-c2cc3cc(C(=O)N(C)c4nc5ccccc5s4)ccc3o2)oc(=O)c(C)c1O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.50
NPC1 O15118 3/20 0.50
RAB9A P51151 3/20 0.50
TP53 P04637 1/20 0.50
CASP3 P42574 1/20 0.50
SMN1; SMN2 Q16637 1/20 0.50
SENP8 Q96LD8 1/20 0.50
SENP7 Q9BQF6 1/20 0.50
SENP6 Q9GZR1 1/20 0.50
HSD17B1 P14061 1/20 0.41
HSD17B2 P37059 1/20 0.41
ALOX15 P16050 1/20 0.41
TSHR P16473 1/20 0.41
KDM4E B2RXH2 5/20 0.37
KMT2A Q03164 2/20 0.37
ALDH1A1 P00352 2/20 0.37
ATM Q13315 2/20 0.36
MAPT P10636 2/20 0.36
NPSR1 Q6W5P4 2/20 0.35
HPGD P15428 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6591699 0.82 MAOB (0.46) NPC1RAB9ATP53CASP3SMN1; SMN2
SCHEMBL6591684 0.81 TOP1 (0.53) LMNANPC1RAB9ACASP3SMN1; SMN2
SCHEMBL6593647 0.81 MEN1 (0.32) LMNANPC1RAB9AKDM4EKMT2A
SCHEMBL6589647 0.80 LIPE (0.36) TP53HSD17B1KMT2AMAPT
SCHEMBL6591627 0.79 KDM4E (0.38) LMNATP53KDM4EKMT2A
SCHEMBL6591785 0.78 TRPV1 (0.40) LMNAKDM4EKMT2AALDH1A1MAPT
SCHEMBL6592236 0.77 MAOB (0.41) LMNAKDM4EKMT2AMAPTGAA
SCHEMBL6594210 0.76 ALDH1A1 (0.47) LMNARAB9ASMN1; SMN2TSHRKMT2A
SCHEMBL6592675 0.74 PDK1 (0.40) NPC1RAB9AKDM4EKMT2AALDH1A1
SCHEMBL6595885 0.74 TP53 (0.46) TP53KDM4EALDH1A1MAPTHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1063235-B1 BENZOFURYLPYRONE DERIVATIVES TEIJIN LTD (JP) 2004-05-12 EP disclosed
US-20030186976-A1 Benzofurylpyrone derivatives TEIJIN LIMITED, MICROBIAL CHEMISTRY RESEARCH FOUNDATION 2003-10-02 US disclosed
US-6589984-B1 Blood cholesterol and triglycerides (TG) themselves are generally insoluble in blood, and they exist as lipoproteins by binding with apolipoproteins. In the body, triglycerides are biosynthesized primarily in the liver from acetyl CoA as TEIJIN LIMITED (JP) 2003-07-08 US disclosed
EP-1063235-A1 BENZOFURYLPYRONE DERIVATIVES TEIJIN LIMITED (JP) 2000-12-27 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030186976-A1 Benzofurylpyrone derivatives PLIN5, ACSL5, PLIN1 LMNA 2644/4885NPC1 512/4885RAB9A 4399/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.